Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab

View source ↗

Summary

This clinical trial update describes a long-term data collection study in France for individuals aged 6 years and older with atopic dermatitis treated with dupi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING